The U.S. will likely emerge the winner in a "cold currency war" that is heating up, an expert said.Currenciesread more
These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Tariffs are the only instrument left for addressing China's systematic and excessive surpluses on its U.S. trades, writes Michael Ivanovitch.US Economyread more
In its latest attempt to build market credibility, China on Monday launched the Science and Technology Innovation Board, or "STAR Market," on which 25 companies were listed.China Economyread more
When Cathy Hsu and Tony Hsieh wanted to build an English language app for Chinese children, they decided to follow Facebook and Google's lead.Start-upsread more
Stocks in Asia traded lower on Monday afternoon, as a Nasdaq-style technology board on the Shanghai Stock Exchange marked its debut.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
There are three things that are triggering the CVS-Aetna deal and one of them is Amazon, former Aetna CEO John Rowe told CNBC on Monday.
The deal would combine CVS' pharmacy business and pharmacy-benefit-manager platform (PBM) with Aetna's insurance business.
"Both of these companies are trying to increase their footprint in health care," Rowe said in an interview with "Closing Bell. "
The deal comes as ecommerce giant Amazon looks to enter the industry, holding preliminary talks with generic-drug makers.
"It's not quite explicit yet what they're planning on doing but whatever it is, it's scaring CVS," Rowe said about Amazon.
Another thing spurring the deal is United Healthcare, which "has had some success with their integrated model of a payer provider," he added.
Lastly, he thinks the failure of recent horizontal mergers, like Aetna-Humana deal, has forced companies to think more vertically across sectors to increase their footprint.
The CEOs of Aetna and CVS both told CNBC on Monday that the merger will reduce health-care costs for consumers immediately.
Rowe believes there are two areas that will see costs reduced — at the point of care at CVS Minute Clinics and in premiums.
"The infusion of millions of Aetna members into CVS program is going to give them more leverage with the drug wholesalers," he said.